potassium phosphates

Generic: potassium phosphate, monobasic potassium phosphate, dibasic injection,

Labeler: amneal pharmaceuticals private limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name potassium phosphates
Generic Name potassium phosphate, monobasic potassium phosphate, dibasic injection,
Labeler amneal pharmaceuticals private limited
Dosage Form SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Active Ingredients

potassium phosphate, dibasic 236 mg/mL, potassium phosphate, monobasic 224 mg/mL

Manufacturer
Amneal Pharmaceuticals Private Limited

Identifiers & Regulatory

Product NDC 80830-1691
Product ID 80830-1691_9256cc7f-e593-4224-8b44-19e8d01d2cb4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216344
Listing Expiration 2026-12-31
Marketing Start 2025-07-09

Pharmacologic Class

Classes
increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] osmotic activity [moa] osmotic laxative [epc] potassium compounds [cs] potassium salt [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 808301691
Hyphenated Format 80830-1691

Supplemental Identifiers

RxCUI
1928569
UPC
0380830169192
UNII
CI71S98N1Z 4J9FJ0HL51

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name potassium phosphates (source: ndc)
Generic Name potassium phosphate, monobasic potassium phosphate, dibasic injection, (source: ndc)
Application Number ANDA216344 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 236 mg/mL
  • 224 mg/mL
source: ndc
Packaging
  • 10 VIAL, SINGLE-DOSE in 1 CARTON (80830-1691-9) / 15 mL in 1 VIAL, SINGLE-DOSE (80830-1691-3)
source: ndc

Packages (1)

80830-1691-9 10 VIAL, SINGLE-DOSE in 1 CARTON (80830-1691-9) / 15 mL in 1 VIAL, SINGLE-DOSE (80830-1691-3)

Ingredients (2)

potassium phosphate, dibasic (236 mg/mL) potassium phosphate, monobasic (224 mg/mL)

Linked Drug Pages (2)

POTASSIUM PHOSPHATES ndc-match (0.9) POTASSIUM PHOSPHATES ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "9256cc7f-e593-4224-8b44-19e8d01d2cb4", "openfda": {"upc": ["0380830169192"], "unii": ["CI71S98N1Z", "4J9FJ0HL51"], "rxcui": ["1928569"], "spl_set_id": ["125121b8-bc4c-44ee-906e-e72f652a5aa6"], "manufacturer_name": ["Amneal Pharmaceuticals Private Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (80830-1691-9)  / 15 mL in 1 VIAL, SINGLE-DOSE (80830-1691-3)", "package_ndc": "80830-1691-9", "marketing_start_date": "20250709"}], "brand_name": "POTASSIUM PHOSPHATES", "product_id": "80830-1691_9256cc7f-e593-4224-8b44-19e8d01d2cb4", "dosage_form": "SOLUTION, CONCENTRATE", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Compounds [CS]", "Potassium Salt [EPC]", "Potassium Salt [EPC]"], "product_ndc": "80830-1691", "generic_name": "potassium phosphate, monobasic potassium phosphate, dibasic injection,", "labeler_name": "Amneal Pharmaceuticals Private Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "POTASSIUM PHOSPHATES", "active_ingredients": [{"name": "POTASSIUM PHOSPHATE, DIBASIC", "strength": "236 mg/mL"}, {"name": "POTASSIUM PHOSPHATE, MONOBASIC", "strength": "224 mg/mL"}], "application_number": "ANDA216344", "marketing_category": "ANDA", "marketing_start_date": "20250709", "listing_expiration_date": "20261231"}